Efficacy and Safety of Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain

A Repeated-Dose Evaluation of a Pain Relieving Drug Use and Safety of OROS Hydromorphone HCI in Patients With Chronic Non-Malignant Pain

NCT00410644 ·Status: COMPLETED ·Phase: PHASE3

A Double-blind Study of Controlled Release OROS Hydromorphone Compared to Placebo in Patients With Chronic Osteoarthritis (OA) Pain

NCT00631319 ·Status: COMPLETED ·Phase: PHASE3

A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg for Acute Pain and the Prevention of OINV

NCT03657810 ·Status: COMPLETED ·Phase: PHASE3

Protocolized vs Discretionary Use of Opioids in Acute Pain

NCT00825370 ·Status: COMPLETED ·Phase: PHASE3

Single-arm Study to Assess the Safety of Hydromorphone Hydrochloride by Intrathecal Administration

NCT01709747 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release)

NCT00410748 ·Status: COMPLETED ·Phase: PHASE3

Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic Pain

NCT00911287 ·Status: COMPLETED ·Phase: PHASE3

A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain

NCT00410878 ·Status: COMPLETED ·Phase: PHASE1

Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain

NCT01428583 ·Status: COMPLETED ·Phase: PHASE3

Trial Comparing Morphine to Hydromorphone in Elderly Patients With Severe Pain

NCT00305058 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Acetaminophen IV vs Hydromorphone IV in the ED

NCT03107481 ·Status: COMPLETED ·Phase: PHASE4

A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients.

NCT00410540 ·Status: COMPLETED ·Phase: PHASE3

Study of Respiratory Depression When Using a Hydromorphone Pain Protocol

NCT01784991 ·Status: TERMINATED ·Phase: NA

An Open-label Study of Hydromorphone Oral Solution in Subjects Aged 28 Days to 16 Years for Postoperative Pain

NCT00465647 ·Status: COMPLETED ·Phase: PHASE4

Study to Test the Effectiveness of Controlled-Release OROS® Hydromorphone HCl Compared to Placebo in Patients With Chronic Low Back Pain

NCT00549042 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain

NCT00225797 ·Status: COMPLETED ·Phase: PHASE3

A One-year, Open-label Study to Assess the Safety and Effectiveness of Extended Release Tramadol HCl in the Treatment of Chronic, Non-malignant Pain.

NCT00347685 ·Status: COMPLETED ·Phase: PHASE3

Hydromorphone Versus Prochlorperazine + Diphenhydramine for Acute Migraine

NCT02389829 ·Status: COMPLETED ·Phase: PHASE4

Titration of Intravenous Hydromorphone

NCT01892709 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Short-term Sustained-release Opioid in Open Abdominal Urologic Surgeries

NCT05375916 ·Status: COMPLETED ·Phase: NA

Evaluate the Safety and Pharmacokinetic Profile of ETR028 and ETR029 in Healthy Adult Subjects

NCT05572190 ·Status: UNKNOWN ·Phase: PHASE1

Safety and Efficacy Study of Hydromorphone and Morphine

NCT00195910 ·Status: COMPLETED ·Phase: PHASE2

Dosing Intervals of Opioid Medication for Chronic Pain

NCT04132011 ·Status: WITHDRAWN ·Phase: PHASE4

Phase III Study of the Safety and Efficacy of Cl-108 in the Treatment of Moderate to Severe Pain

NCT01780428 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain

NCT00226421 ·Status: COMPLETED ·Phase: PHASE3